Correlation Between Atlas For and Memphis Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Atlas For and Memphis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atlas For and Memphis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atlas For Investment and Memphis Pharmaceuticals, you can compare the effects of market volatilities on Atlas For and Memphis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atlas For with a short position of Memphis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atlas For and Memphis Pharmaceuticals.

Diversification Opportunities for Atlas For and Memphis Pharmaceuticals

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Atlas and Memphis is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Atlas For Investment and Memphis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Memphis Pharmaceuticals and Atlas For is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atlas For Investment are associated (or correlated) with Memphis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Memphis Pharmaceuticals has no effect on the direction of Atlas For i.e., Atlas For and Memphis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Atlas For and Memphis Pharmaceuticals

Assuming the 90 days trading horizon Atlas For Investment is expected to generate 0.68 times more return on investment than Memphis Pharmaceuticals. However, Atlas For Investment is 1.47 times less risky than Memphis Pharmaceuticals. It trades about 0.16 of its potential returns per unit of risk. Memphis Pharmaceuticals is currently generating about 0.08 per unit of risk. If you would invest  24.00  in Atlas For Investment on October 12, 2024 and sell it today you would earn a total of  101.00  from holding Atlas For Investment or generate 420.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy79.22%
ValuesDaily Returns

Atlas For Investment  vs.  Memphis Pharmaceuticals

 Performance 
       Timeline  
Atlas For Investment 

Risk-Adjusted Performance

25 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Atlas For Investment are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Atlas For reported solid returns over the last few months and may actually be approaching a breakup point.
Memphis Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Memphis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Atlas For and Memphis Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Atlas For and Memphis Pharmaceuticals

The main advantage of trading using opposite Atlas For and Memphis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atlas For position performs unexpectedly, Memphis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Memphis Pharmaceuticals will offset losses from the drop in Memphis Pharmaceuticals' long position.
The idea behind Atlas For Investment and Memphis Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing